n-acetylglucosaminylasparagine has been researched along with Carbohydrate-Deficient Glycoprotein Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahina, M; Fujinawa, R; Hirayama, H; Kajii, Y; Suzuki, T; Tozawa, R | 1 |
| Couse, MH; de Sain-van der Velden, MGM; Friedman, JM; Gerrits, J; Haijes, HA; Jans, JJM; Prinsen, HCMT; Selby, KA; van der Ham, M; van Hasselt, PM; van Karnebeek, CDM; Verhoeven-Duif, NM; Willems, AP | 1 |
2 other study(ies) available for n-acetylglucosaminylasparagine and Carbohydrate-Deficient Glycoprotein Syndrome
| Article | Year |
|---|---|
Reversibility of motor dysfunction in the rat model of NGLY1 deficiency.
Topics: Acetylglucosamine; Animals; Congenital Disorders of Glycosylation; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Gliosis; Humans; Inflammation; Injections, Intraventricular; Motor Activity; Neurons; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Rats; Rats, Transgenic; Transgenes | 2021 |
Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation.
Topics: Acetylglucosamine; Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Child, Preschool; Congenital Disorders of Glycosylation; Dried Blood Spot Testing; Female; Humans; Infant; Male; Mass Spectrometry; Mutation; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 2019 |